Disruptors & Dominators
Act now to claim your 55%
discount and receive:
- 55% OFF 1 year of Disruptors & Dominators ($109 value)
- BONUS Report #1: The Next FDA Signal: How to Profit Off First Class Drugs
- BONUS Report #2: The Ultimate AI Drug Stock
- BONUS Report #3: 3 Under-the-Radar Companies Powering the AI Data Center Explosion
- BONUS Report #4: The User’s Guide to Disruptors and Dominators
- One year of premium access to our 53,000 Weiss Ratings
- FREE Weiss Ratings Daily e-letter
- 24-7 Market Flash Alerts
- Exclusive and confidential online briefings
- 365-Day Refund Policy
The FDA has begun sending out a quiet, but powerful signal to a select handful of drug companies.
And 97% of the time the FDA sends this signal — the stock involved goes up in the following months.
It’s happened 74 out of 76 times …
For an average gain of 117% in eight months.
Now, I believe the FDA is on the verge of releasing its next signal.
It could happen as soon as 9:30 a.m. tomorrow …
Or a few weeks from now.
But when it does, one promising biotech company could benefit from it …
I want you to get in before they potentially get this signal …
So, you can maximize your profit potential.
That’s why I’m going to make you a special offer today.
Sign up for one of year of Disruptors and Dominators …
And we’ll give you 55% OFF the regular retail price.
Plus, we’ll immediately send you the name of this promising biotech stock …
The one I think will be next to get the FDA’s promising signal.
This is the best price we’ve ever offered for these resources. And it may not last long.
If you’d like to claim your discount and your bonus AI stock reports, please review the information below and fill out our simple order form to sign up.
Here’s everything you’ll receive:
SPECIAL DISCOUNT
55% OFF One Full Year of Michael Robinson’s Disruptors & Dominators
On the first Friday of every month, you’ll get a new issue of Disruptors & Dominators with a brand-new recommendation from Michael Robinson. We’ll show you the best stock market investments that combine the stability of safe, long-term sustainable growth with the opportunity for faster, often explosive growth.
NEW SPECIAL REPORT
The Next FDA Signal: How to Profit Off First-Class Drugs.
Since 2016, the FDA has sent out a special signal. Only certain drugs receive it. And when they do, the share price of the company involved has gone up 97% of the time. The average gain was 117% in 8 months. Now, I believe the next FDA signal is coming — and I think investors have a chance to benefit, whether the drugs eventually get approved or not.
NEW SPECIAL REPORT
The Ultimate AI Drug Stock
Typically, it takes years and millions of dollars to earn FDA approval. But this company believes they can cut the testing time down to just a matter of days, thanks to AI. They even partnered with Microsoft to do it. On top of that, this company already has a handful of high-performing drugs on the market, generating $5 billion a year. And they have a deep pipeline with multiple potential winners. Inside this report, I’ll share my optimal buy up to price for the stock — and how AI could take them to another level.
NEW SPECIAL REPORT
3 Under-the-Radar Companies Powering the AI Data Center Explosion
We’ve identified three additional companies worth watching thanks to their integral role in this coming wave of AI data centers. They’ve positioned themselves as essential to the massive data center build-out, meaning they could also be at the forefront of explosive AI growth in 2024 and beyond.
NEW SPECIAL REPORT
The User’s Guide to Disruptors & Dominators
This comprehensive guide is essential to get the most out of your Disruptors and Dominators subscription. It outlines the investing philosophy that’s helped Michael Robinson stay ahead of the curve for over three decades. Michael will lay out the way he evaluates tech companies and how it allows him to find the next big thing – before the rest of the market.
MEMBER EXCLUSIVE
One year of premium access to our 53,000 Weiss Ratings
Over the past two decades, investors could have more than tripled their money on 1,306 tech stock trades. This rating system has provided an average gain of 220% during this period, and that includes the losers. It’s the only completely unbiased independent ratings system.
MEMBER EXCLUSIVE
24-7 Flash Alerts
Anytime there are critical time-sensitive opportunities, massive swings in the market or any news on our recommendations, we’ll get that information to you as soon as possible. We won’t leave you hanging with just one issue a month. We’ll keep you in the loop on all of the market news.
FREE BONUS
Weiss Ratings Daily E-Letter
Another way to stay up to date on the latest from all our analysts at Weiss Ratings is through our three-times-a-week e-letter. We’ll cover all the day’s headlines from an alternative investing perspective. We’re not just going to regurgitate the same stuff you see on CNN. We give you our twist. Oftentimes, it will be the exact opposite of what the talking heads say.
MEMBER EXCLUSIVE
Confidential, Online Briefings
Every once in a while, a story will be too big for just an email or a monthly issue. Instead, we’ll get on video and explain all the details and even answer your questions right there. (Please remember, we are legally forbidden from giving individual investment advice.)
You’re Protected by a 365-Day Money-Back Guarantee
All subscribers are eligible for a full refund at any time during the next 12 months.
Please, take the next year to try out Disruptors & Dominators and see if it’s right for you. If you’re not satisfied for any reason, simply call our customer service team and we’ll give you a full refund.
Michael Robinson
Editor, Disruptors & Dominators
Disruptors & Dominators
Your special price today:
$109 $49
To get started, please fill out our secure order form below.